Production (Stage)
Interpace Biosciences, Inc.
IDXG
$0.80
$0.022.56%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 241.02% | 255.27% | 468.77% | 127.54% | 111.94% |
| Total Depreciation and Amortization | -38.45% | -53.28% | -73.33% | -70.41% | -60.72% |
| Total Amortization of Deferred Charges | -60.71% | -- | -100.00% | -75.44% | -56.25% |
| Total Other Non-Cash Items | -45.39% | -38.89% | -57.07% | -93.36% | -90.73% |
| Change in Net Operating Assets | -47.08% | -217.09% | -171.37% | 48.09% | 38.54% |
| Cash from Operations | 128.60% | 22.62% | 93.93% | 281.73% | 148.97% |
| Capital Expenditure | -95.84% | -86.38% | -69.66% | -25.97% | -17.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -92.20% | -94.13% |
| Cash from Investing | -1,596.00% | -906.90% | 14.85% | -100.32% | -100.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -132.14% | -124.00% | -64.00% | -310.00% | -833.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -43.75% | -43.75% | 70.37% | 70.37% | 70.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 93.56% | 93.56% | -- | -- | -- |
| Cash from Financing | -25.79% | -15.40% | -154.49% | -526.25% | -424.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.95% | -53.16% | -128.58% | -203.24% | -211.54% |